This signature, the Grog T regulatory CD4 signature (Grog.Treg.1), did not correlate with higher performance within any of the cancer types it was derived from (Fig. 4A and B, Supplemental Table 6) [29]. This evidence concerns the gene CXCL3 and cancer.